OMDA Form 4 — 712 RSUs granted to director; 111,200 held indirectly
Rhea-AI Filing Summary
Insider transaction summary: A Form 4 shows that Trevor Fetter, a director of Omada Health, Inc. (OMDA), was granted 712 restricted stock units (RSUs) on 10/05/2025 as payment under the non-employee director compensation program in lieu of retainer fees. Each RSU converts to one share at settlement and the grant carried a reported price of $0 (i.e., issued as compensation). After the grant, the filing reports Mr. Fetter directly beneficially owns 10,705 shares and indirectly beneficially owns 111,200 shares through an LLC he solely controls, for a combined beneficial position of 121,905 shares.
The form was signed by an attorney-in-fact on 10/07/2025. The filing discloses that settlement timing follows plan terms and that the indirect holdings are held via the limited liability company of which Mr. Fetter is the sole member.
Positive
- Director alignment: 712 RSUs were granted as compensation, aligning the director's incentives with shareholders
- Substantial insider holdings: Combined beneficial ownership of 121,905 shares signals meaningful insider stake
Negative
- None.
Insights
Director received equity compensation and retains significant indirect holdings.
The 712 RSU grant is a routine non-cash director compensation action that increases the director's direct stake to 10,705 shares while confirming substantial indirect ownership of 111,200 shares. Equity pay in the form of RSUs aligns director incentives with shareholder value without immediate cash outlay.
Key dependencies include the plan's settlement schedule and vesting terms; the filing notes settlement per program terms but does not state vesting dates. Watch for future Forms (4 or 5) that disclose settlement dates or additional grants within the next 12 months.
Grant issued at no cash cost; dilution is likely immaterial at this size.
The RSUs were issued at a reported price of $0, indicating they were granted as compensation rather than a purchase. A 712-share grant is small relative to the director's total combined position of 121,905 shares, suggesting limited incremental dilution from this single grant.
Risks to monitor include the aggregate run-rate of equity awards to directors and executives; additional periodic RSU grants could increase share count over time. Look for periodic disclosures of total shares reserved under the equity plan.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 712 | $0.00 | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- Represents restricted stock units ("RSUs") that were granted pursuant to the Issuer's Non-Employee Director Compensation Program (the "Program") in lieu of retainer fees. Each RSU represents the right to receive one (1) share of Common Stock, with settlement to take place either (i) on a date selected by the Reporting Person pursuant to the Program or (ii) as otherwise provided by the Program. Shares held by a limited liability company of which the Reporting Person is the sole member.
